Back to
Dr Dongli Liu

Dr Dongli Liu

Postdoctoral Fellow
Medicine & Health
School of Clinical Medicine

Dr Dongli Liu is a postdoctoral researcher with extensive expertise in molecular and cell biology, including patient-derived primary cell culture, and strong bioinformatics skills in next-generation sequencing (NGS). Since joining the Gynaecological Cancer Research Group at the University of New South Wales Sydney in 2018, Dr Liu has led multiple research projects aimed at identifying prognostic biomarkers and novel therapies for ovarian and endometrial cancers. Her work has also focused on developing patient-derived 3D cancer models to test novel therapies in molecular subtype of malignancies. 
E-mail
dongli.liu@unsw.edu.au
Location
Lowy Cancer Research Centre
  • Journal articles | 2025
    Cortesi M; Liu D; Powell E; Barlow E; Warton K; Giordano E; Ford CE, 2025, 'Development and validation of a computational tool to predict treatment outcomes in cells from high-grade serous ovarian cancer patients', Bioengineering and Translational Medicine, 10, http://dx.doi.org/10.1002/btm2.70082
    Journal articles | 2025
    Gunther K; Fisher T; Liu D; Abbott J; Ford CE, 2025, 'Endometriosis is not the endometrium: Reviewing the over-representation of eutopic endometrium in endometriosis research', ELIFE, 14, http://dx.doi.org/10.7554/eLife.103825
    Journal articles | 2025
    Gunther K; Liu D; Cortesi M; Powell E; Nesbitt-Hawes E; Abbott JA; Ford CE, 2025, 'Patient-derived epithelial cell organoids mimic the phenotypic complexity of endometriosis subtypes.', Hum Reprod, http://dx.doi.org/10.1093/humrep/deaf230
    Journal articles | 2025
    Liu D; Glubb D; O'Mara T; Ford CE, 2025, 'The Multi-Kinase Inhibitor GZD824 (Olverembatinib) Shows Pre-Clinical Efficacy in Endometrial Cancer', Cancer Medicine, 14, http://dx.doi.org/10.1002/cam4.70531
    Journal articles | 2025
    Liu D; Vandenberg CJ; Sini P; Waldmeier L; Baumgartinger R; Pisarsky L; Petroczi G; Ratnayake G; Scott CL; Ford CE, 2025, 'The antibody–drug conjugate targeting ROR1, NBE-002, is active in high-grade serous ovarian cancer preclinical models', Therapeutic Advances in Medical Oncology, 17, http://dx.doi.org/10.1177/17588359251332471
    Journal articles | 2024
    Cortesi M; Liu D; Powell E; Barlow E; Warton K; Ford CE, 2024, 'Accurate Identification of Cancer Cells in Complex Pre-Clinical Models Using a Deep-Learning Neural Network: A Transfection-Free Approach', Advanced Biology, 8, http://dx.doi.org/10.1002/adbi.202400034
    Journal articles | 2024
    Cortesi M; Liu D; Powell E; Barlow E; Warton K; Ford CE, 2024, 'Accurate Identification of Cancer Cells in Complex Pre‐Clinical Models Using a Deep‐Learning Neural Network: A Transfection‐Free Approach (Adv. Biology 11/2024)', Advanced Biology, 8, http://dx.doi.org/10.1002/adbi.202470112
    Journal articles | 2024
    Cortesi M; Liu D; Yee C; Marsh DJ; Ford CE, 2024, 'Author Correction: A comparative analysis of 2D and 3D experimental data for the identification of the parameters of computational models (Scientific Reports, (2023), 13, 1, (15769), 10.1038/s41598-023-42486-3)', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-023-50403-x
    Journal articles | 2024
    Liu D; Powell E; Wan KM; Athavale R; Loo C; Ford CE, 2024, 'Abstract B014: Patient-derived organoid models for drug screening in molecular subtypes of endometrial cancer', Clinical Cancer Research, 30, pp. B014 - B014, http://dx.doi.org/10.1158/1557-3265.endo24-b014
    Journal articles | 2024
    Matthews B; Wong-Brown M; Liu D; Yee C; Dickson KA; Schneider J; Islam S; Head R; Martin JH; Ford CE; Marsh DJ; Bowden NA, 2024, 'Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer', Molecular Therapy Oncology, 32, http://dx.doi.org/10.1016/j.omton.2024.200911
    Journal articles | 2023
    Cortesi M; Liu D; Yee C; Marsh DJ; Ford CE, 2023, 'A comparative analysis of 2D and 3D experimental data for the identification of the parameters of computational models', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-42486-3
    Journal articles | 2023
    Fivelman B; Liu D; Ford C; Wan KM; Loo C, 2023, 'Mixed large cell neuroendocrine carcinoma and high grade serous carcinoma of the ovary: a histopathological case report', Pathology, 55, pp. S55 - S55, http://dx.doi.org/10.1016/j.pathol.2022.12.178
    Journal articles | 2022
    Liu D; Gunther K; Enriquez LA; Daniels B; O’Mara TA; Tang K; Spurdle AB; Ford CE, 2022, 'Author Correction: ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target (Scientific Reports, (2020), 10, 1, (13906), 10.1038/s41598-020-70924-z)', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-15043-7
    Journal articles | 2022
    Liu D; Kaufmann GF; Breitmeyer JB; Dickson KA; Marsh DJ; Ford CE, 2022, 'The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells', Pharmaceutics, 14, http://dx.doi.org/10.3390/pharmaceutics14040837
    Journal articles | 2021
    Joshi N; Liu D; Dickson KA; Marsh DJ; Ford CE; Stenzel MH, 2021, 'An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticles', Journal of Materials Chemistry B, 9, pp. 9123 - 9135, http://dx.doi.org/10.1039/d1tb01837j
    Journal articles | 2021
    Liu D; Enriquez L; Ford CE, 2021, 'Ror2 is epigenetically regulated in endometrial cancer', Cancers, 13, pp. 1 - 16, http://dx.doi.org/10.3390/cancers13030383
    Journal articles | 2021
    Liu D; Sharbeen G; Phillips P; Johns AL; Gill AJ; Chantrill LA; Timpson P; Chou A; Pajic M; Dwarte T; Herrmann D; Vennin C; Cox TR; Pereira B; Ritchie S; Reed DA; Chambers CR; Metcalf X; Nobis M; Waddell N; Pearson JV; Patch AM; Nones K; Newell F; Mukhopadhyay P; Addala V; Kazakoff S; Holmes O; Leonard C; Wood S; Grimmond SM; Hofmann O; Samra JS; Pavlakis N; Arena J; High HA; Asghari R; Merrett ND; Das A; Cosman PH; Ismail K; Stoita A; Williams D; Spigellman A; Lam VW; McLeod D; Kirk J; Kench JG; Grimison P; Sandroussi C; Goodwin A; Mead RS; Tucker K; Andrews L; Texler M; Forrest C; Ballal M; Fletcher D; Beilin M; Feeney K; Epari K; Mukhedkar S; Zeps N; Nguyen NQ; Ruszkiewicz AR; Worthley C; Chen J; Brooke-Smith ME; Papangelis V; Clouston AD; Barbour AP; O’Rourke TJ; Fawcett JW; Slater K; Hatzifotis M; Hodgkinson P; Nikfarjam M; Eshleman JR; Hruban RH; Wolfgang CL; Scarpa A; Lawlor RT; Corbo V; Bassi C; Biankin AV; Jamieson NB; Chang DK; Dreyer SB; Ford CE, 2021, 'ROR1 and ROR2 expression in pancreatic cancer', BMC Cancer, 21, http://dx.doi.org/10.1186/s12885-021-08952-9
    Journal articles | 2021
    Werner B; Yuwono N; Duggan J; Liu D; David C; Srirangan S; Provan P; DeFazio A; Arora V; Farrell R; Lee YC; Warton K; Ford C, 2021, 'Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer', Gynecologic Oncology, 162, pp. 720 - 727, http://dx.doi.org/10.1016/j.ygyno.2021.06.028
    Journal articles | 2020
    Liu D; Gunther K; Enriquez LA; Daniels B; O’Mara TA; Tang K; Spurdle AB; Ford CE, 2020, 'ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target', Scientific Reports, 10, http://dx.doi.org/10.1038/s41598-020-70924-z
    Journal articles | 2019
    Costanzo A; Liu D; Nowson C; Duesing K; Archer N; Bowe S; Keast R, 2019, 'A low-fat diet up-regulates expression of fatty acid taste receptor gene FFAR4 in fungiform papillae in humans: a co-twin randomised controlled trial', British Journal of Nutrition, 122, pp. 1212 - 1220, http://dx.doi.org/10.1017/S0007114519002368
    Journal articles | 2018
    Liu D; Costanzo A; Evans MDM; Archer NS; Nowson C; Duesing K; Keast R, 2018, 'Expression of the candidate fat taste receptors in human fungiform papillae and the association with fat taste function', British Journal of Nutrition, 120, pp. 64 - 73, http://dx.doi.org/10.1017/S0007114518001265
    Journal articles | 2016
    Archer NS; Liu D; Shaw J; Hannan G; Duesing K; Keast R, 2016, 'A comparison of collection techniques for gene expression analysis of human oral taste tissue', Plos One, 11, http://dx.doi.org/10.1371/journal.pone.0152157
    Journal articles | 2016
    Liu D; Archer N; Duesing K; Hannan G; Keast R, 2016, 'Mechanism of fat taste perception: Association with diet and obesity', Progress in Lipid Research, 63, pp. 41 - 49, http://dx.doi.org/10.1016/j.plipres.2016.03.002
  • Preprints | 2024
    Cortesi M; Li J; Liu D; Guo T; Dokos S; Warton K; Ford C, 2024, A novel approach for the quantification of single-cell adhesion dynamics from microscopy images, http://dx.doi.org/10.1101/2024.10.08.616409
    Preprints | 2024
    Cortesi M; Liu D; Powell E; Barlow E; Warton K; Giordano E; Ford C, 2024, Development and validation of a computational tool to predict treatment outcomes in cells from High-Grade Serous Ovarian Cancer patients, http://dx.doi.org/10.1101/2024.10.02.616212
    Preprints | 2023
    Cortesi M; Liu D; Powell E; Barlow E; Warton K; Ford C, 2023, Accurate identification of cancer cells in complex pre-clinical models using deep-learning: a transfection-free approach, http://dx.doi.org/10.1101/2023.10.15.562411
    Preprints | 2023
    Cortesi M; Liu D; Yee C; Marsh D; Ford C, 2023, Model Parameter identification using 2D vs 3D experimental data: a comparative analysis, http://dx.doi.org/10.1101/2023.05.17.541071
    Conference Abstracts | 2023
    Liu D; Powell E; Wan KM; Athavale R; Loo C; Ford CE, 2023, 'Patient-derived organoid models for drug screening in molecular subtypes of endometrial cancer', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, Vol. 30, presented at AACR Special Conference on Endometrial Cancer - Transforming Care through Science, MA, Boston, 16 November 2023 - 18 November 2023, http://dx.doi.org/10.1158/1557-3265.ENDO24-B014
    Preprints | 2023
    Matthews B; Wong-Brown M; Liu D; Yee C; Dickson K-A; Schneider J; Islam S; Head R; Martin J; Ford C; Marsh D; Bowden N, 2023, Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer, http://dx.doi.org/10.22541/au.169580899.90269470/v1
    Conference Papers | 2021
    Liu D; Enriquez L; Daniels B; O'Mara T; Tang K; Ford C, 2021, 'Abstract PO042: ROR2 is epigenetically regulated in endometrial cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. PO042 - PO042, http://dx.doi.org/10.1158/1557-3265.endomet20-po042
    Conference Papers | 2021
    Liu D; Kaufmann GF; Breitmeyer JB; Dickson K-A; Marsh DJ; Ford CE, 2021, 'Abstract 1062: Inhibition of ovarian and endometrial cancer cell proliferation by an anti-ROR1 monoclonal antibody', in Cancer Research, American Association for Cancer Research (AACR), pp. 1062 - 1062, http://dx.doi.org/10.1158/1538-7445.am2021-1062
    Conference Papers | 2021
    Liu D; Kaufmann GF; Breitmeyer JB; Dickson K-A; Marsh DJ; Ford CE, 2021, 'Inhibition of ovarian and endometrial cancer cell proliferation by an anti-ROR1 monoclonal antibody.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 10 April 2021 - 21 May 2021
    Conference Abstracts | 2020
    Liu D; Gunther K; Daniels B; O'Mara T; Tang K; Ford C, 2020, 'ROR1: A novel target in endometrial cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 80, presented at AACR Annual Meeting, ELECTR NETWORK, 22 June 2020 - 24 June 2020, http://dx.doi.org/10.1158/1538-7445.AM2020-2942
    Conference Papers | 2020
    Liu D; John M; Henry CE; Christie EL; Bowtell DDL; Tang K; Heinzelmann-Schwarz V; Kennedy C; Boros J; DeFazio A; Ford CE, 2020, 'Abstract A41: ROR1 is associated with ovarian cancer progression and chemoresistance', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. A41 - A41, http://dx.doi.org/10.1158/1557-3265.ovca19-a41
    Conference Papers | 2016
    Liu D; Archer N; Duesing K; Keast R, 2016, 'Expression of Candidate Fat Taste Receptors in Human Fungiform Papillae', in CHEMICAL SENSES, OXFORD UNIV PRESS, FL, Bonita Springs, pp. E32 - E32, presented at 38th Annual Meeting of the Association-for-Chemoreception-Sciences (AChemS), FL, Bonita Springs, 20 April 2016 - 23 April 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383854300081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

2024 UNSW 3Rs grant, Endometriosis Australia 2021 project grant, 2022 MAZDA Foundation and Australian Gynaecological Cancer Foundation grant, 2023 UNSW EMCR seed grant, and 2022 UNSW Medicine ECAN-Ramaciotti Centre ECR grant.

  • 2025 WHRTN Emerging Leaders Fellowship Program Scholarship;

  • 2023 ANZGOG Annual Scientific Meeting Best Poster Award, Brisbane;

    2022 ANZGOG Annual Scientific Meeting 2022 Abstract Award, Melbourne;

    2017 GEDDA AWARD by the 16th International Congress on Twin Studies Madrid, Spain;

    2016 Chinese Government Award for Outstanding Self-financed Students Abroad.

  •  
  •  

My Research Supervision

One Honours students and two PhD candidates.